Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group box 1 pseudogene 3 (HMGB1P3) is a processed pseudogene in the human genome that is homologous to the high mobility group box 1 (HMGB1) protein-coding gene. Pseudogenes like HMGB1P3 generally do not produce functional proteins and are not considered classical therapeutic targets such as receptors, enzymes, or transporters. There is currently no evidence to suggest that HMGB1P3 has an independent biological function, role in disease, or direct drug interactions. The parental gene HMGB1, in contrast, is a well-studied nuclear protein and a therapeutic target in inflammation and cancer, but these properties do not extend to HMGB1P3[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 1 pseudogene 3 (HMGB1P3).